Breast Cancer: Assessing Response to Neoadjuvant Chemotherapy by Using US-guided Near-Infrared Tomography

PURPOSE: To assess initial breast tumor hemoglobin (Hb) content before the initiation of neoadjuvant chemotherapy, monitor the Hb changes at the end of each treatment cycle, and correlate these findings with tumor pathologic response. MATERIALS AND METHODS: The HIPAA-compliant study protocol was app...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhu, Quing, DeFusco, Patricia A., Ricci, Andrew, Cronin, Edward B., Hegde, Poornima U., Kane, Mark, Tavakoli, Behnoosh, Xu, Yan, Hart, Jesse, Tannenbaum, Susan H.
Format: Artigo
Idioma:Inglês
Publicat: Radiological Society of North America, Inc. 2013
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3558877/
https://ncbi.nlm.nih.gov/pubmed/23264349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1148/radiol.12112415
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars